Ambovex^® as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial

References

• ParkinDMGlobal cancer statistics in the year 2000Lancet Oncol20012953354311905707
   PubMed Web of Science ®Google Scholar
• MazzantiRGramantieriLBolondiLHepatocellular carcinoma: epidemiology and clinical aspectsMol Aspects Med2008291–213014318061252
   PubMed Web of Science ®Google Scholar
• CookGCHepatocellular carcinoma: one of the world’s most common malignanciesQ J Med1985572237057083001812
   PubMedGoogle Scholar
• El-SeragHBRudolphKLHepatocellular carcinoma: epidemiology and molecular carcinogenesisGastroenterology200713272557257617570226
   PubMed Web of Science ®Google Scholar
• NguyenMHKeeffeEBGeneral managementBest Pract Res Clin Gastroenterol200519116117415757811
   PubMed Web of Science ®Google Scholar
• KanwalFEl-SeragHBHepatocellular cancer care: cost is important but only one factor of disease burdenJ Hepatol2009501101219019482
   PubMed Web of Science ®Google Scholar
• DonatoFTaggerAGelattiUAlcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and womenAm J Epidemiol2002155432333111836196
   PubMed Web of Science ®Google Scholar
• Di BisceglieAMLyraACSchwartzMLiver Cancer NetworkHepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic statusAm J Gastroenterol20039892060206314499788
   PubMed Web of Science ®Google Scholar
• ParkinDMThe global health burden of infection-associated cancers in the year 2002Int J Cancer2006118123030304416404738
   PubMed Web of Science ®Google Scholar
• El-SeragHBHepatocellular carcinoma: recent trends in the United StatesGastroenterology20041275 Suppl 1S27S3415508094
   PubMed Web of Science ®Google Scholar
• GomaaAIKhanSAToledanoMBWakedITaylor-RobinsonSDHepatocellular carcinoma: epidemiology, risk factors and pathogenesisWorld J Gastroenterol200814274300430818666317
   PubMed Web of Science ®Google Scholar
• NguyenMHWhittemoreASGarciaRTRole of ethnicity in risk for hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosisClin Gastroenterol Hepatol20042982082415354283
   PubMed Web of Science ®Google Scholar
• ChinPLChuDZClarkeKGOdom-MaryonTYenYWagmanLDEthnic differences in the behavior of hepatocellular carcinomaCancer19998591931193610223232
   PubMed Web of Science ®Google Scholar
• HassanMMHwangLYHattenCJRisk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitusHepatology20023651206121312395331
   PubMed Web of Science ®Google Scholar
• MukaiyaMNishiMMiyakeHHirataKChronic liver diseases for the risk of hepatocellular carcinoma: a case-control study in Japan. Etiologic association of alcohol consumption, cigarette smoking and the development of chronic liver diseasesHepatogastroenterology19984524232823329951917
   PubMedGoogle Scholar
• ChenZMLiuBQBorehamJWuYPChenJSPetoRSmoking and liver cancer in China: case-control comparison of 36,000 liver cancer deaths vs. 17,000 cirrhosis deathsInt J Cancer2003107110611212925964
   PubMed Web of Science ®Google Scholar
• MizoueTTokuiNNishisakaKProspective study on the relation of cigarette smoking with cancer of the liver and stomach in an endemic regionInt J Epidemiol200029223223710817118
   PubMed Web of Science ®Google Scholar
• TanakaKHirohataTTakeshitaSHepatitis B virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: a case-control study in Fukuoka, JapanInt J Cancer19925145095141318264
   PubMed Web of Science ®Google Scholar
• La VecchiaCNegriEDecarliAD’AvanzoBFranceschiSRisk factors for hepatocellular carcinoma in northern ItalyInt J Cancer19884268728762847988
   PubMed Web of Science ®Google Scholar
• EvansAAChenGRossEAShenFMLinWYLondonWTEight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differencesCancer Epidemiol Biomarkers Prev200211436937611927497
   PubMed Web of Science ®Google Scholar
• ChenMFHwangTLJengLBJanYYWangCSChouFFHepatic resection in 120 patients with hepatocellular carcinomaArch Surg19891249102510282549912
   PubMedGoogle Scholar
• LiawYFTaiDIChuCMEarly detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective studyGastroenterology19869022632672416625
   PubMed Web of Science ®Google Scholar
• YoshimiFNagaoTInoueSComparison of hepatectomy and transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: necessity for prospective randomized trialHepatology19921637027061324216
   PubMed Web of Science ®Google Scholar
• CastellsABruixJBruCTreatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injectionHepatology1993185112111268225217
   PubMed Web of Science ®Google Scholar
• KotohKSakaiHSakamotoSThe effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomyAm J Gastroenterol19948921941988304302
   PubMed Web of Science ®Google Scholar
• BuscariniLDi StasiMBuscariniEClinical presentation, diagnostic work-up and therapeutic choices in two consecutive series of patients with hepatocellular carcinomaOncology19965332042098643222
   PubMed Web of Science ®Google Scholar
• FarmerDGRosoveMHShakedABusuttilRWCurrent treatment modalities for hepatocellular carcinomaAnn Surg199421932362478147605
   PubMed Web of Science ®Google Scholar
• OhtoMYoshikawaMSaishoHEbaraMSugiuraNNonsurgical treatment of hepatocellular carcinoma in cirrhotic patientsWorld J Surg199519142467740809
   PubMed Web of Science ®Google Scholar
• LüthSHuberSSchrammCEctopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific TregsJ Clin Invest2008118103403341018802476
   PubMed Web of Science ®Google Scholar
• AbeMThomsonAWAntigen processing and presentation in the liverGerswhinMEVierlingJMMannsMPLiver Immunology: Principles and PracticeTotowa, NJHumana Press Inc2007486
   Google Scholar
• KamadaNDaviesHSRoserBReversal of transplantation immunity by liver graftingNature198129258268408427022223
   PubMed Web of Science ®Google Scholar
• Seyfert-MargolisVTurkaLAMarking a path to transplant toleranceJ Clin Invest200811882684268618654643
   PubMed Web of Science ®Google Scholar
• De MinicisSSekiEUchinamiHGene expression profiles during hepatic stellate cell activation in culture and in vivoGastroenterology200713251937194617484886
   PubMed Web of Science ®Google Scholar
• FriedmanSLLiver fibrosis – from bench to bedsideJ Hepatol200338Suppl 1S38S5312591185
   PubMed Web of Science ®Google Scholar
• LimmerASacherTAlferinkJFailure to induce organ-specific autoimmunity by breaking of tolerance: importance of the microenvironmentEur J Immunol1998288239524069710217
   PubMed Web of Science ®Google Scholar
• LlovetJMRicciSMazzaferroVSHARP Investigators Study GroupSorafenib in advanced hepatocellular carcinomaN Engl J Med2008359437839018650514
   PubMed Web of Science ®Google Scholar
• JodoSKobayashiSNakajimaYElevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinomaClin Exp Immunol199811221661719649177
   PubMed Web of Science ®Google Scholar
• Phase I clinical trial to evaluate the safety, tolerability and clinical pharmacology profile of Ambovex ampoulesHeidar Ghaleb IND of Ambovex200927–48203294
   Google Scholar
• Phase II clinical trial to evaluate the safety and efficacy of Ambovex Ampules given for 3 years to patients with chronic HCV infectionAmr Helmy, IASL Meeting in Cairo, Sept 2006 IND of Ambovex295415
   Google Scholar
• An open label phase II study in hepatitis C infected patients, co-infected with human immune-deficiency virus (HIV) who have failed, intolerant or having contra-indications for standard therapyMichael Lange, MDMPH IND of Ambovex2010416521
   Google Scholar